Mexico says there is no evidence its lettuce caused US outbreak

This is primarily a brand-risk event, not a fundamental earnings event, unless the investigation expands beyond a single ingredient path. For YUM, the market should care more about a temporary traffic hit and legal/PR spend than about menu economics; the real downside is if the story lingers long enough to push franchised operators into slower same-store sales recovery and modest promo pressure over the next 1-2 quarters.

The second-order issue is supply-chain tightening across QSR and fast-casual concepts that rely on fresh produce. That tends to help larger operators with centralized procurement and food-safety protocols, while smaller chains and salad-heavy concepts can see a bigger multiple hit because investors extrapolate a one-off incident into higher compliance costs and lower consumer trust. If the FDA/Cofepris process turns into a broader supplier audit, expect a short-term mix shift toward cooked or pre-processed items, which is mildly inflationary for food costs but usually manageable.

The contrarian take is that the market may be overpricing the immediate financial damage and underpricing the speed of mean reversion if no additional cases emerge. The key falsifier is a confirmed causal link plus additional geographies or product categories; absent that, the move should fade within days to weeks, not months. Over 6-18 months, the only durable effect would be if Yum or peers change sourcing standards in a way that structurally raises input costs, but that is more likely a margin headwind than a top-line problem.